A Study to Compare FKB327 Long-term Safety, Efficacy and Immunogenicity With Humira® in Rheumatoid Arthritis Patients
Status:
Completed
Trial end date:
2018-01-18
Target enrollment:
Participant gender:
Summary
The purpose of the study is to compare the long-term safety, effectiveness and immunogenicity
of FKB327 in comparison to Humira® in rheumatoid arthritis patients who have completed study
FKB327-002 and have inadequate disease control on methotrexate.